|
|
Exchange: |
Nasdaq Small Cap |
Security
Type: |
Common |
Shares
Out: |
17,320,000 |
Market
Cap: |
45.03(M) |
Last
Volume: |
50,402 |
Avg
Vol: |
50,263 |
52
Week Range: |
$0.76 - $3.33 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile XTL Biopharmaceuticals is a biopharmaceutical company engaged in the acquisition and development of pharmaceutical drugs for the treatment of autoimmune diseases. Co.'s existing drug, hCDR1, is a treatment for systemic lupus erythematosus (SLE) and Sjogren's syndrome (SS). hCDR1 is a peptide that is administered subcutaneously and acts as a disease-specific treatment to modify the SLE-related autoimmune process. hCDR1 is also Phase II-ready for the treatment of SS. SS is a chronic autoimmune disorder affecting lacrimal and salivary gland function (glandular) but may also affect other organs and systems (extraglandular) such as the kidneys, and gastrointestinal system, among others.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-02-18 |
2023-11-17 |
2023-05-19 |
2022-05-19 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Perceptive Life Sciences Master Fund Ltd |
10% Owner |
|
2008-11-19 |
4 |
S |
$0.15 |
$1,466,880 |
I/I |
(9,600,000) |
20,580,260 |
|
- |
|
Perceptive Life Sciences Master Fund Ltd |
10% Owner |
|
2008-11-18 |
4 |
S |
$0.14 |
$4,339,608 |
I/I |
(30,450,370) |
0 |
|
- |
|
Weiner Ben-Zion |
Director |
|
2008-08-27 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
50,000 |
|
- |
|
Weiss Michael S |
Director |
|
2008-08-22 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
25,000 |
|
- |
|
Bradley Scott |
10% Owner |
|
2008-06-10 |
4 |
B |
$3.23 |
$164,730 |
I/I |
51,000 |
3,072,560 |
1.5 |
- |
|
Bradley Scott |
10% Owner |
|
2008-06-09 |
4 |
B |
$3.36 |
$112,896 |
I/I |
33,600 |
3,070,520 |
1.5 |
- |
|
Bradley Scott |
10% Owner |
|
2008-06-06 |
4 |
B |
$3.43 |
$343,000 |
I/I |
100,000 |
3,069,180 |
1.5 |
- |
|
Bradley Scott |
10% Owner |
|
2008-06-05 |
4 |
B |
$3.15 |
$967,000 |
I/I |
300,000 |
3,065,180 |
1.5 |
- |
|
Bradley Scott |
10% Owner |
|
2008-06-04 |
4 |
B |
$2.99 |
$74,750 |
I/I |
25,000 |
3,053,180 |
1.5 |
- |
|
Bradley Scott |
10% Owner |
|
2008-06-03 |
4 |
B |
$3.03 |
$1,214,212 |
I/I |
400,730 |
3,052,180 |
1.5 |
- |
|
Bradley Scott |
10% Owner |
|
2008-05-02 |
4 |
B |
$3.88 |
$194,000 |
I/I |
50,000 |
3,036,140 |
1.5 |
- |
|
Bradley Scott |
10% Owner |
|
2008-05-01 |
4 |
B |
$3.75 |
$393,750 |
I/I |
105,000 |
3,034,140 |
1.5 |
- |
|
Cho Michael |
10% Owner |
|
2008-04-30 |
4 |
B |
$3.74 |
$480,579 |
I/I |
128,370 |
3,029,940 |
1.5 |
- |
|
Cho Michael |
10% Owner |
|
2008-04-29 |
4 |
B |
$3.54 |
$811,028 |
I/I |
229,240 |
3,024,810 |
1.5 |
- |
|
Cho Michael |
10% Owner |
|
2008-04-10 |
4 |
B |
$3.56 |
$357,590 |
I/I |
100,000 |
3,015,650 |
1.5 |
- |
|
Bradley Scott |
10% Owner |
|
2008-04-01 |
4 |
B |
$3.16 |
$951,913 |
I/I |
301,000 |
3,005,650 |
1.5 |
- |
|
Bradley Scott |
10% Owner |
|
2008-03-28 |
4 |
B |
$2.90 |
$72,460 |
I/I |
25,000 |
2,985,600 |
1.5 |
- |
|
Bradley Scott |
10% Owner |
|
2008-03-18 |
4 |
B |
$3.12 |
$508,593 |
I/I |
163,000 |
2,984,350 |
1.5 |
- |
|
Bradley Scott |
10% Owner |
|
2008-03-14 |
4 |
B |
$3.32 |
$1,540,366 |
I/I |
463,000 |
2,977,700 |
1.5 |
- |
|
Bradley Scott |
10% Owner |
|
2008-03-13 |
4 |
B |
$3.37 |
$50,054 |
I/I |
14,820 |
2,949,920 |
1.5 |
- |
|
Bradley Scott |
10% Owner |
|
2008-03-13 |
4 |
B |
$3.37 |
$784,180 |
I/I |
232,180 |
55,205,500 |
1.5 |
- |
|
Bradley Scott |
10% Owner |
|
2008-03-12 |
4 |
B |
$3.35 |
$88,587 |
I/I |
26,400 |
2,935,100 |
1.5 |
- |
|
Bradley Scott |
10% Owner |
|
2008-03-12 |
4 |
B |
$3.35 |
$1,387,857 |
I/I |
413,600 |
54,973,320 |
1.5 |
- |
|
Bradley Scott |
10% Owner |
|
2008-03-11 |
4 |
B |
$3.30 |
$2,049,121 |
I/I |
619,000 |
2,908,700 |
1.5 |
- |
|
Bradley Scott |
10% Owner |
|
2008-03-10 |
4 |
B |
$3.15 |
$4,573,930 |
I/I |
1,420,000 |
2,866,800 |
1.5 |
- |
|
73 Records found
|
|
Page 1 of 3 |
|
|